Skip to main content

Featured Videos | view more

Advances in Immunotherapy for Pancreatic Cancer: Robert H. Vonderheide, MD, DPhil (Part 1) Video

Advances in Immunotherapy for Pancreatic Cancer: Robert H. Vonderheide, MD, DPhil (Part 1)

Dr. Robert H. Vonderheide, Director of the Abramson Cancer Center at Penn Medicine, reviews the triumphs and challenges of cancer therapy over the last quarter century, focusing on new tools and the motivation driving the focus on immunotherapy ...

Brain Aneurysms Update | Treatment and Case Reports Video

Brain Aneurysms Update | Treatment and Case Reports

Dr. Omar Choudri, MD, Co-Director of Cerebrovascular & Endovascular Neurosurgery at Penn Medicine, offers and update on the management of patients diagnosed with brain aneurysms and insight on treatment of aneurysmal disease.

Brain Aneurysms Update | Causes and Risk Factors Video

Brain Aneurysms Update | Causes and Risk Factors

Dr. Omar Choudri, Co-Director of Cerebrovascular and Endovascular Neurosurgery at Penn Medicine discusses the management of neuro vascular aneurysmal disease.

Featured Articles & Documents |view more

Neurogenetics Team Forms with "Tsunami" of Breakthroughs Looming News

Neurogenetics Team Forms with "Tsunami" of Breakthroughs Looming

The wealth of information that’s become available over the last 10 to 20 years coupled with the rapid evolution of the technology that can analyze it has dramatically transformed neurogenetics.

Hepatic Arterial Infusion Chemotherapy for Colorectal Liver Metastases Document

Hepatic Arterial Infusion Chemotherapy for Colorectal Liver Metastases

Surgeons and oncologists within the Department of Surgery at Penn Medicine are using adjuvant hepatic artery infusion chemotherapy with systemic chemotherapy to prevent recurrence in patients with resected colorectal liver metastases...

Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer Document

Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

Investigators in the Division of Gynecologic Oncology at Penn Medicine are conducting a clinical trial to investigate combination therapy with olaparib and AZD6738 in women with high grade serous ovarian or primary peritoneal and/or fallopian tube cancer.

News Updates

Advance in Understanding Actin Sheds Light on Cell Function

Wednesday, April 8, 2020 3:00 PM

A tiny chemical modification on one of the most abundant and important proteins in cells, actin, has long been somewhat mysterious, its function not fully understood, but scientists from the Perelman School of Medicine at the University ...

Awards and Accolades: April 2020

Tuesday, April 7, 2020 3:24 PM

Learn how Penn clinicians and professionals are being honored by their peers

Philadelphia Eagles Owner Jeffrey Lurie Gives $1 Million to Penn Medicine Research to Fight COVID-19

Friday, April 3, 2020 3:55 PM

Philadelphia Eagles owner Jeffrey Lurie today announced a $1 million contribution to Penn Medicine to establish the COVID-19 Immunology Defense Fund, laying the foundation for the world’s foremost experts to fight the novel coronavirus pandemic.

View More

Physician Blog

Tuesday, April 7, 2020 12:00 AM

Penn is a participant in a new Phase I clinical trial to evaluate hydroxychloroquine for COVID-19 disease as part INOVIO’s COVID-19 Vaccine Trial.

COVID-19 Webinar: What Healthcare Providers Need to Know (04/02/20) with Penn Epidemiologist Kathleen Murphy, MD

Monday, April 6, 2020 8:00 PM

Our recent webinar, COVID-19: What Healthcare Providers Need to Know, featured Infectious Disease specialist Kathleen Murphy, MD, Associate Hospital Epidemiologist at the Hospital of the University of Pennsylvania.

This Week: COVID-19 Webinars

Tuesday, March 31, 2020 8:00 PM

Learn more about COVID-19 research and current clinical guidelines in two webinars featuring Penn experts.

View More

Penn Events

Health Equity Week 2020

Monday, April 6 – Friday, April 10, 2020 Health Equity Week is an annual conference designed to facilitate expert-driven conver-sations on health and health care dispari-ties with the goal of advancing health equity through ...

UPDATES IN ONCOLOGY 2020 PHILADELPHIA with Proceedings from International Medical Meetings - Online Webinar

Online Webinar Thursday, June 18, 2020, 5 – 9:20pm Type of Event: CME Course, Conference Sponsor: Abramson Cancer Center Program Overview: This activity is designed to efficiently discuss the most recent ...

View More




Penn Medicine, Philadelphia, PA 800-789-7366 © , The Trustees of the University of Pennsylvania

Powered by the BroadcastMed Network